Вплив лозартану на ультраструктурну морфологію формених елементів крові у хворих на цукровий діабет та артеріальну гіпертензію
DOI:
https://doi.org/10.26641/2307-0404.2013.2.15945Ключові слова:
артеріальна гіпертензія, цукровий діабет 2-го типу, ультраструктура тромбоцитів і лейкоцитів, лозартанАнотація
Ultrastructural changes of blood cells in with patients with hypertension of 1-2-degree, in patients with diabetes mellitus type 2 at compensation and subcompensation phase as well as in patients with diabetes mellitus and hypertension during correction of blood pressure with losartan was defined. It is shown that in patients with hypertension of 1-2-degree relative content of activated platelets does not differ from the normal level. In patients with diabetes mellitus type 2 at compensation or subcompensation phase increase of degree of platelet activation, regardless of presence (150.9%) or absence of hypertension (141.5%) is observed. Conducted antihypertensive therapy does not affect the spontaneous activation of platelets within 1 year. In patients with hypertension potential aggregation of platelets is the most sensitive element of platelet hemostasis damage, which can be normalized beginning with 6-th month of losartan treatment. In patients with diabetes mellitus type 2 with hypertension elevation of platelet aggregation is the most significant (75.4%) and a reliable effect of antihypertensive therapy on limitation of platelet aggregation is achieved in 9 months of treatment. The degree of platelet degranulation is not different from the norm in patients with hypertension and significantly elevated in patients with diabetes mellitus type 2 (by 81.0%), during 1-year observation a constant level of the parameter is revealed. In the group of patients with diabetes mellitus and hypertension, where the original content of degranulated platelets is sharply increased (by 76.2%), a significant positive dynamics in the course of treatment with losartan is observed.Посилання
Изменении активности тромбоцитарного гемо-стаза больных артериальной гипертонией с метабо-лическими нарушениями / Л.Н. Мингазетдинова, Э.Г. Му¬талова, Н.П. Каневская [и др.] // Соврем. мед. технологии. – 2004. – № 3. – С. 79-81.
Интенсивность образования активных моле-кул тромбина и контрактильные свойства сгустков у больных гипертонической болезнью второй стадии / В.Б. Воробьев, Н.В. Карлина, А.Л. Зибарев, В.Е. Прут-ков // Соврем. наукоемкие технологии. – 2008. - № 12. – С. 57-58.
Медведев И.Н. Ослабление агрегационной спо¬собности тромбоцитов у больных артериальной гипертонией при метаболическом синдроме на фоне лозартана / И.Н. Медведев, Т.А. Кумова // Рос. кар-диол. журнал. – 2008. - № 5. – С. 53-55.
Миронов А.А. Методы электронной микро-скопии в биологии и медицине: метод. руководство / А.А. Миронов, Я.Ю. Комиссарчик, В.А. Миронов. – СПб.: Наука, 1994. – 400 с.
Носова Т.Ю. Современные взгляды на меха-низмы нарушения функций тромбоцитов при арте-риальной гипертонии с абдоминальным ожирением / Т.Ю. Носова, И.Н. Медведев // Успехи соврем. естес-тво¬знания. – 2007. - № 12. – С. 371-373.
Роль нейтрофилов и прооксидинтного потен-циала крови в развитии эндотелиальной дисфункции при артериальной гипертензии / Е.А. Васькина, Д.Д. Ци¬рендоржиев, Л.М. Демина [и др.] // Бюллетень СО РАМН. – 2003. – № 2. – С. 107-112.
Шилов А.М. Артериальная гипертония и рео-логические свойства крови / А.М. Шилов, М.В. Мель-ник. – М.: БАРС, 2005. – 328 с.
Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus / F. Carmassi, M. Mo¬rale, R. Puccetti [et al.] // Thromb. Res. – 1992. – Vol. 67. – P. 643-654.
Epstein M. Diabetes and hypertension: the bad companions / M. Epstein // J. Hypertension. – 1997. – Vol. 15, Suppl. 2. – P. 55-62.
Leukocyte-platelet aggregates as a marker of inflammation / L. Bouriachkovskaia, I. Uchitel, N. Dov-latova [et al.] // Platelets. – 2004. – Vol. 16, N 8. – P. 483-484.
Sawatzke C. L. Fixation and embedding of small volumes of platelets for transmission electron microscopy / C.L. Sawatzke, C.C. Solomons // J. Clin. Pathol.–1980.–Vol. 33, N 6. – P. 600-602.
Mingazetdinova LN, Mutalova EG, Kanevskaya NP. Izmenenii aktivnosti trombotsitarnogo gemostaza bol¬nyih arterialnoy gipertoniey s metabolicheskimi naru-sheniyami. Sovrem med tehnologii.2004;3:79-81.
Vorobev VB, Karlina NV, Zibarev AL, Prutkov VE. Intensivnost obrazovaniya aktivnyih molekul trom-bina i kontraktilnyie svoystva sgustkov u bolnyih gipertonicheskoy boleznyu vtoroy stadii. Sovrem nauko-emkie tehnologii. 2008;12:57-58.
Medvedev IN, Kumova TA. Oslablenie agregat-sionnoy sposobnosti trombotsitov u bolnyih arterialnoy gipertoniey pri metabolicheskom sindrome na fone lo-zartana. Ros kardiol zhurnal. 2008;5:53-55.
Mironov AA, Komissarchik YaYu, Mironov VA. Metodyi elektronnoy mikroskopii v biologii i meditsine: metod. rukovodstvo. SPb: Nauka. 1994;400.
Nosova Tyu, Medvedev IN. Sovremennyie vzglya¬dyi na mehanizmyi narusheniya funktsiy trombo-tsitov pri arterialnoy gipertonii s abdominalnyim ozhire-niem. Uspehi sovrem estestvoznaniya. 2007;12:371-3.
Vaskina EA, Tsirendorzhiev DD, Demina LM. Rol neytrofilov i prooksidintnogo potentsiala krovi v raz¬vitii endotelialnoy disfunktsii pri arterialnoy gipertenzii. Byulleten SO RAMN. 2003;2:107-12.
Shilov AM, Melnik MV. Arterialnaya gipertoniya i reologicheskie svoystva krovi. M: BARS. 2005;328.
Carmassi F, Morale M, Puccetti R. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res. 1992;67:643-54.
Epstein M. Diabetes and hypertension: the bad companions. J Hypertension. 1997;15(2):55-62.
Bouriachkovskaia L, Uchitel I, Dovlatova N. Leu¬kocyte-platelet aggregates as a marker of inflammation. Platelets. 2004;16(8):483-4.
Sawatzke CL, Solomons CC. Fixation and embe-d¬ding of small volumes of platelets for transmission electron microscopy. J Clin Pathol. 1980;33(6):600-2.
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2017 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
